Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations

References

• Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH. Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol. 2016;15:1182–94.
   PubMed Web of Science ®Google Scholar
• Ji AL, Zhang X, Chen WW, Huang WJ. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J Med Genet. 2017;54:145–54.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043–8.
   PubMed Web of Science ®Google Scholar
• Belzil VV, Katzman RB, Petrucelli L. ALS and FTD: an epigenetic perspective. Acta Neuropathol. 2016;132:487–502.
   PubMed Web of Science ®Google Scholar
• Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol. 2015;11:266–79.
   PubMed Web of Science ®Google Scholar
• Figueroa-Romero C, Hur J, Bender DE, Delaney CE, Cataldo MD, Smith AL, et al. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One. 2012;7:e52672.
   PubMed Web of Science ®Google Scholar
• Lam L, Chin L, Halder RC, Sagong B, Famenini S, Sayre J, et al. Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients. Faseb J. 2016;30:3461–73.
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Messina P, Conti E, Sala G, Cecchi M, Airoldi L, et al. Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:98–105.
   PubMed Web of Science ®Google Scholar
• Gene report of major ALS genes in ALSoD. http://alsod.iop.kcl.ac.uk/. Accessed May 9, 2017.
   Google Scholar
• Conforti FL, Barone R, Fermo SL, Giliberto C, Patti F, Gambardella A, et al. Sporadic motor neuron disease in a familial novel SOD1 mutation: incomplete penetrance or chance association? Amyotroph Lateral Scler. 2011;12:220–2.
   PubMed Web of Science ®Google Scholar
• Corrado L, D'Alfonso S, Bergamaschi L, Testa L, Leone M, Nasuelli N, et al. SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS). Neuromuscul Disord. 2006;16:800–4.
   PubMed Web of Science ®Google Scholar
• Kim W, Kim JS, Lee KS, Gwoun YJ, Kim JM, Lee KH. Anticipation and phenotypic heterogeneity in Korean familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation. J Clin Neurol. 2007;3:38–44.
   PubMed Web of Science ®Google Scholar
• Kobayashi Z, Tsuchiya K, Kubodera T, Shibata N, Arai T, Miura H, et al. FALS with Gly72Ser mutation in SOD1 gene: report of a family including the first autopsy case. J Neurol Sci. 2011;300:9–13.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Madia F, Conte A, Marangi G, Zollino M, Del Grande A, et al. SOD1 G93D mutation presenting as paucisymptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:479–82.
   PubMed Web of Science ®Google Scholar
• Penco S, Lunetta C, Mosca L, Maestri E, Avemaria F, Tarlarini C, et al. Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease. J Mol Neurosci. 2011;44:25–30.
   PubMed Web of Science ®Google Scholar
• Restagno G, Lombardo F, Sbaiz L, Mari C, Gellera C, Alimonti D, et al. The rare G93D mutation causes a slowly progressing lower motor neuron disease. Amyotroph Lateral Scler. 2008;9:35–9.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Lattante S, Zollino M, Conte A, Marangi G, Del Grande A, et al. SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant. Neurobiol Aging. 2011;32:1924.e15–18.
   Web of Science ®Google Scholar
• Orrell RW, Marklund SL, deBelleroche JS. Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser). J Neurol Sci. 1997;153:46–9.
   PubMed Web of Science ®Google Scholar
• García-Redondo A, Bustos F, Juan Y Seva B, Del Hoyo P, Jiménez S, Campos Y, et al. Molecular analysis of the superoxide dismutase 1 gene in Spanish patients with sporadic or familial amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:274–8.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554–60.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Tarlarini C, Lunetta C, Mosca L, Avemaria F, Riva N, Mantero V, et al. Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis. Eur J Neurol. 2015;22:1474–81.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat Protoc. 2008;3:1903–8.
   PubMed Web of Science ®Google Scholar
• Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18:1427–31.
   PubMed Web of Science ®Google Scholar
• Migheli F, Stoccoro A, Coppedè F, Wan Omar WA, Failli A, Consolini R, et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One. 2013;8:e52501.
   PubMed Web of Science ®Google Scholar
• Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, Martin LJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci. 2011;31:16619–36.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xi Z, Ghani M, Jia P, Pal M, Werynska K, et al. Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28. J Neurol Neurosurg Psychiatry. 2016;87:1268–70.
   PubMed Web of Science ®Google Scholar
• Oates N, Pamphlett R. An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler. 2007;8:83–6.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J, et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2016;21:1112–24.
   PubMed Web of Science ®Google Scholar
• Xi Z, Yunusova Y, van Blitterswijk M, Dib S, Ghani M, Moreno D, et al. Identical twins with the C9orf72 repeat expansion are discordant for ALS. Neurology. 2014;83:1476–8.
   PubMed Web of Science ®Google Scholar
• Callaghan B, Feldman D, Gruis K, Feldman E. The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegenerative Dis. 2011;8:1–8.
   PubMed Web of Science ®Google Scholar
• Garzillo EM, Miraglia N, Pedata P, Feola D, Lamberti M. Risk agents related to work and amyotrophic lateral sclerosis: An occupational medicine focus. Int J Occup Med Environ Health. 2016;29:355–67.
   PubMed Web of Science ®Google Scholar
• Rooney J. Further thoughts on mercury, epigenetics, genetics and amyotrophic lateral sclerosis. Neurodegenerative Dis. 2011;8:523–4.
   PubMed Web of Science ®Google Scholar
• Coppedè F. Genetics and epigenetics of Parkinson's disease. Scientificworldjournal. 2012;2012:489830.
   PubMed Web of Science ®Google Scholar
• Sanchez-Mut JV, Gräff J. Epigenetic Alterations in Alzheimer's Disease. Front Behav Neurosci. 2015;9:347.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the “LEARn” model (latent early-life associated regulation) may explain the triggering of AD. Car. 2007;4:219–28.
   Web of Science ®Google Scholar
• Sung HY, Choi BO, Jeong JH, Kong KA, Hwang J, Ahn JH. Amyloid beta-mediated hypomethylation of heme oxygenase 1 correlates with cognitive impairment in Alzheimer's disease. PLoS One. 2016;11:e0153156.
   PubMed Web of Science ®Google Scholar
• Coppedè F. The potential of epigenetic therapies in neurodegenerative diseases. Front Genet. 2014;5:220.
   PubMed Web of Science ®Google Scholar
• Oh YS, Kim SH, Cho GW. Functional restoration of amyotrophic lateral sclerosis patient-derived mesenchymal stromal cells through inhibition of DNA methyltransferase. Cell Mol Neurobiol. 2016;36:613–320.
   PubMed Web of Science ®Google Scholar